DPS-2: A Novel Dual MEK/ERK and PI3K/AKT Pathway Inhibitor with Powerful Ex Vivo and In Vivo Anticancer Properties
DPS-2:一种新型双重 MEK/ERK 和 PI3K/AKT 通路抑制剂,具有强大的体外和体内抗癌特性
期刊:Translational Oncology
影响因子:4.5
doi:10.1016/j.tranon.2019.04.005
Maria Goulielmaki, Nikos Assimomytis, Jan Rozanc, Eleni Taki, Ioannis Christodoulou, Leonidas G Alexopoulos, Vassilis Zoumpourlis, Alexandros Pintzas, Demetris Papahatjis
信号转导
肿瘤
IHC
MAPK/ERK
PI3K/Akt
Goat
IgG